A detailed history of D'Orazio & Associates, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, D'Orazio & Associates, Inc. holds 7,158 shares of PFE stock, worth $191,404. This represents 0.03% of its overall portfolio holdings.

Number of Shares
7,158
Previous 7,547 5.15%
Holding current value
$191,404
Previous $211,000 1.9%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$27.7 - $31.39 $10,775 - $12,210
-389 Reduced 5.15%
7,158 $207,000
Q2 2024

Aug 07, 2024

SELL
$25.26 - $29.6 $2,121 - $2,486
-84 Reduced 1.1%
7,547 $211,000
Q1 2024

May 08, 2024

SELL
$25.89 - $29.73 $6,265 - $7,194
-242 Reduced 3.07%
7,631 $211,000
Q4 2023

Feb 07, 2024

SELL
$26.13 - $33.94 $17,324 - $22,502
-663 Reduced 7.77%
7,873 $226,000
Q3 2023

Oct 10, 2023

SELL
$32.09 - $37.51 $45,439 - $53,114
-1,416 Reduced 14.23%
8,536 $283,000
Q2 2023

Aug 04, 2023

BUY
$36.12 - $41.79 $131,946 - $152,658
3,653 Added 57.99%
9,952 $365,000
Q1 2023

Apr 21, 2023

SELL
$39.39 - $51.28 $84,018 - $109,380
-2,133 Reduced 25.3%
6,299 $256,000
Q4 2022

Jan 25, 2023

SELL
$41.75 - $54.5 $94,689 - $123,606
-2,268 Reduced 21.2%
8,432 $0
Q3 2022

Oct 13, 2022

BUY
$43.76 - $53.42 $64,721 - $79,008
1,479 Added 16.04%
10,700 $468,000
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $48,484 - $57,487
1,042 Added 12.74%
9,221 $483,000
Q1 2022

May 02, 2022

BUY
$45.75 - $56.69 $21,273 - $26,360
465 Added 6.03%
8,179 $423,000
Q4 2021

Feb 07, 2022

BUY
$41.32 - $61.25 $38,799 - $57,513
939 Added 13.86%
7,714 $456,000
Q3 2021

Nov 10, 2021

BUY
$39.25 - $50.42 $21,273 - $27,327
542 Added 8.7%
6,775 $291,000
Q2 2021

Aug 04, 2021

BUY
$35.91 - $40.68 $25,783 - $29,208
718 Added 13.02%
6,233 $244,000
Q1 2021

May 05, 2021

SELL
$33.49 - $37.77 $8,339 - $9,404
-249 Reduced 4.32%
5,515 $200,000
Q4 2020

Feb 05, 2021

SELL
$33.47 - $42.56 $3,012 - $3,830
-90 Reduced 1.54%
5,764 $212,000
Q3 2020

Oct 19, 2020

BUY
$31.75 - $37.25 $5,143 - $6,034
162 Added 2.85%
5,854 $215,000
Q2 2020

Jul 22, 2020

BUY
$30.12 - $36.54 $481 - $584
16 Added 0.28%
5,692 $186,000
Q1 2020

Apr 28, 2020

SELL
$27.03 - $38.62 $72,413 - $103,462
-2,679 Reduced 32.06%
5,676 $185,000
Q4 2019

Jan 22, 2020

BUY
$32.92 - $37.36 $987 - $1,120
30 Added 0.36%
8,355 $327,000
Q3 2019

Nov 01, 2019

BUY
$32.49 - $42.13 $13,353 - $17,315
411 Added 5.19%
8,325 $299,000
Q2 2019

Aug 05, 2019

SELL
$36.98 - $41.52 $5,029 - $5,646
-136 Reduced 1.69%
7,914 $343,000
Q1 2019

May 01, 2019

BUY
$37.5 - $41.2 $7,050 - $7,745
188 Added 2.39%
8,050 $342,000
Q4 2018

Jan 24, 2019

BUY
$38.47 - $43.86 $39,239 - $44,737
1,020 Added 14.91%
7,862 $343,000
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $861 - $1,045
25 Added 0.37%
6,842 $302,000
Q2 2018

Aug 09, 2018

SELL
$32.98 - $35.16 $2,440 - $2,601
-74 Reduced 1.07%
6,817 $247,000
Q1 2018

May 04, 2018

BUY
$31.91 - $37.02 $4,180 - $4,849
131 Added 1.94%
6,891 $245,000
Q4 2017

Feb 06, 2018

BUY
$33.26 - $35.29 $38,315 - $40,654
1,152 Added 20.54%
6,760 $245,000
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $173,848 - $191,513
5,608
5,608 $200,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track D'Orazio & Associates, Inc. Portfolio

Follow D'Orazio & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D'Orazio & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on D'Orazio & Associates, Inc. with notifications on news.